Reduce the Armour Thyroid Dose Immediately
Your patient is biochemically overreplaced with thyroid hormone, and the dose should be reduced to prevent cardiovascular and skeletal complications, even though TSH appears normal. The elevated free T3 at 7.2 (above normal range) indicates excessive T3 exposure from the desiccated thyroid preparation.
Why This Matters
Armour Thyroid contains a 4:1 ratio by weight of T4 to T3 1, which translates to a much higher T3-to-T4 ratio than the human thyroid naturally produces. This formulation inherently predisposes patients to supraphysiologic T3 levels while maintaining seemingly "normal" TSH and T4 values.
The critical issue: TSH is NOT a reliable therapeutic endpoint when using combination T4/T3 preparations like Armour Thyroid. The guidelines explicitly state that TSH is the most reliable endpoint for levothyroxine monotherapy 1, but this principle breaks down with desiccated thyroid because:
- The high T3 content suppresses TSH more potently than T4 alone
- T3 has direct tissue effects independent of TSH feedback
- Your patient's elevated free T3 indicates tissue-level thyrotoxicosis despite "normal" TSH
Immediate Risks of Elevated T3
The guidelines warn that overtreatment—even subtle overtreatment—causes 1:
- Cardiovascular complications: atrial fibrillation (especially in elderly), increased cardiovascular mortality
- Skeletal complications: accelerated bone loss (particularly concerning in postmenopausal women)
- Affective disturbances: anxiety, tremor, palpitations
These risks occur even when TSH appears "normal" if free T3 is elevated.
Recommended Management Algorithm
Step 1: Reduce Armour Thyroid Dose
- Decrease current dose by 15-30 mg (one-quarter to one-half grain) 2
- The FDA label indicates most patients require 60-120 mg/day for maintenance 2
Step 2: Recheck Labs in 4-6 Weeks
- Measure TSH, free T4, AND free T3
- Target: Free T3 in mid-normal range, TSH 0.5-2.5 mIU/L, free T4 mid-to-upper normal range
- Do NOT rely on TSH alone for dose titration with desiccated thyroid
Step 3: Consider Switching to Levothyroxine Monotherapy
This is the preferred long-term strategy because:
- Guidelines recommend levothyroxine as standard therapy 1
- TSH becomes a reliable monitoring parameter
- More predictable pharmacokinetics without T3 spikes
- Reduced risk of iatrogenic thyrotoxicosis
If switching:
- Calculate approximate levothyroxine equivalent: 60 mg Armour Thyroid ≈ 100 mcg levothyroxine
- Start levothyroxine at ~1.6 mcg/kg ideal body weight 1
- Recheck thyroid function in 6-8 weeks
Special Consideration for Congenital Athyreosis
Your patient has complete thyroid agenesis, meaning zero endogenous thyroid hormone production. This makes them:
- Entirely dependent on exogenous replacement
- More vulnerable to both under- and over-replacement
- Requiring lifelong, consistent therapy
Research in congenital hypothyroidism shows that some patients develop persistently elevated TSH despite normal T4/free T4, often due to inadequate free T3 levels at the pituitary 3, 4. However, your patient has the opposite problem—excessive free T3—which is causing inappropriate TSH suppression and tissue-level thyrotoxicosis.
Common Pitfall to Avoid
Do not be falsely reassured by "normal" TSH and T4 when using Armour Thyroid. The high T3 content creates a biochemical pattern where TSH appears controlled while tissues are exposed to excessive thyroid hormone. Free T3 measurement is essential for monitoring desiccated thyroid therapy 2.
Monitoring After Dose Adjustment
- Recheck thyroid function every 4-6 weeks until stable
- Once stable, monitor every 3-6 months
- Always measure TSH, free T4, and free T3 when using desiccated thyroid
- Assess for clinical signs of hyperthyroidism: tachycardia, tremor, weight loss, anxiety, heat intolerance
The elevated free T3 represents biochemical overtreatment that requires immediate dose reduction to prevent long-term cardiovascular and skeletal morbidity 1.